Unstable angina pectoris of Coronary Heart Disease
Conditions
Interventions
Intervention group:Guanxindanshen Dropping Pills+ Atorvastatin
Sponsors
China Academy of Chinese Medical Sciences Guang'anmen Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Between 30 and 80 years of age; 2. Either have a previous history of myocardial infarction or have at least one coronary artery stenosis >=50% confirmed by coronary angiography; 3. Subjects must currently be hospitalized withunstable angina; 4. Participants must have the diagnosis of Blood stasis syndrome; 5. Participants must either currently be taking statin medications or have a serum LDL-C >=2.08mmol/L.
Exclusion criteria
Exclusion criteria: 1. Infection, fever, trauma, burn injury, or surgery within one month prior to recruitment; 2. Subjects have previously undergone or currently be planning to undergo surgical intervention for CHD; 3. Patients with severe heart failure indicated by an ejection fraction < 35% ; 4. Study participants currently be taking antibiotics or using TCM preparations that relieve fever or clear internal heat; 5. Patients with a reduced platelet count or a tendency to bleed or hemorrhage; 6. Patients were diagnosed with cancer; 7. Patients with tuberculosis, or rheumatoid arthritis or other autoimmune diseases; 8. Patients have a history of serious pulmonary, hepatic, renal, neurological, psychiatric, or hematological diseases; 9. Patients who participate in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The inflammatory factor level;Serum high-sensitivity C reactive protein level; | — |
Countries
China
Contacts
Public ContactXiangning Cui
Academy of Chinese Medical Sciences Guang‘anmen Hospital
Outcome results
None listed